CD123 Immunohistochemical Expression in Acute Myeloid Leukemia is Associated With Underlying FLT3-ITD and NPM1 Mutations-Reference-Cited by-同舟云学术

CD123 Immunohistochemical Expression in Acute Myeloid Leukemia is Associated With Underlying FLT3-ITD and NPM1 Mutations

Published:2013-05 Issue:3 Volume:21 Page:212-217
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Rollins-Raval Marian,Pillai Raju,Warita Katsuhiko,Mitsuhashi-Warita Tomoko,Mehta Rohtesh,Boyiadzis Michael,Djokic Miroslav,Kant Jeffrey A.,Roth Christine G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference25 articles.

1. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.;Grimwade;Blood,2010

2. Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.;Estey;Am J Hematol,2012

3. Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.;Ravandi;Leuk Res,2010

4. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.;Schlenk;N Engl J Med,2008

5. Comparison of bone marrow aspiration and bone marrow biopsy in neoplastic diseases.;Hamid;Gulf J Oncol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic features of early haematopoietic and leukaemia stem cells;International Journal of Laboratory Hematology;2024-07-24

2. Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study;The Lancet Oncology;2024-03

3. Leukemia classification using different CNN-based algorithms-comparative study;Neural Computing and Applications;2024-02-28

4. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches;Biochemical Pharmacology;2023-09

5. Utility of mutation-specific immunohistochemical markers for predicting post-induction remission among acute myeloid leukemia patients – A prognostic test accuracy study;Journal of Hematology and Allied Sciences;2023-07-25